10X Health, a company specializing in personalized health optimization, has appointed Jeff Zwiefel as its new President and Chief Operating Officer. This appointment is part of a broader expansion of the company's executive leadership team, which the company states is a significant step toward becoming a global leader in precision health, human performance, and longevity. Zwiefel brings over thirty years of executive experience in the health and wellness industry, most recently serving as President and COO of Life Time, where he helped scale the company into a multi-billion-dollar platform.
In his new role, Zwiefel will focus on accelerating 10X Health's growth strategy, scaling operations, and expanding its footprint. This is a pivotal moment in the evolution of health and wellness, said Zwiefel. He noted a consumer shift toward integrated, personalized approaches that combine diagnostics, lifestyle, and medical insight, stating that 10X Health is uniquely positioned to lead in this space. The company has simultaneously assembled a new executive team with expertise across healthcare, life sciences, AI, human performance, and finance.
The expanded leadership team includes Dr. Kent Bradley as Chief Medical Executive, Shivani Kaul as Chief Legal Officer, Ashish Ash Bhuskute as Chief Financial Officer, Prasanna Sivakumar as Chief Technology Officer, Will Sliger as Chief Marketing Officer, and Craig Gatzlaff as Vice President of Sales. According to the company, this team brings experience in scaling complex organizations and delivering measurable business outcomes. 10X Health is assembling one of the most experienced and dynamic leadership teams in the industry, said Brandon Dawson, Chairman and CEO of Cardone Ventures & 10X Health.
The leadership expansion supports 10X Health's mission to build a fully integrated, global ecosystem for personalized health. The company utilizes a data-driven approach, leveraging advanced diagnostics and biomarker analysis to create individualized protocols. Its global expansion is being facilitated through strategic initiatives, including Cardone Ventures' investment in REVIV Global and a partnership with M42 in Abu Dhabi to advance precision nutrition and human performance in the Middle East. These moves, combined with the strengthened U.S. leadership, aim to establish 10X Health as the only company offering a unified global platform for science-backed, personalized health solutions.
By integrating diagnostics, medical insight, and performance optimization, 10X Health seeks to shift health management from reactive care to proactive, precision-driven outcomes. The company plans to continue expanding its offerings, enhancing clinical capabilities, and pursuing strategic partnerships across consumer and enterprise channels to deliver individualized solutions at scale worldwide. The appointment of Zwiefel and the broader executive team expansion signals a concerted effort to capitalize on the growing demand for personalized health and position the company as a dominant player in the global market for precision wellness and longevity services.
